Current disease status-First occurrence of the cancer - Page 19 of 59 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

A comparison of how FEC120 treatment vs EC-docetaxel treatment affect survival in patients with node-positive primary breast cancer

A comparison of how FEC120 treatment vs EC-docetaxel treatment affect survival in patients with node-positive primary breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study compared the side effects and outcome of two drug regimens in women with high-risk node-positive breast cancer (BC). Both treatment regimens were found to have similar survival outcomes. Some background Standard treatment in node positive BC (cancer that has spread to the lymph nodes) consists of two categories of...

Read More

The role of dexamethasone mouthwash in preventing everolimus-related stomatitis in women with breast cancer

The role of dexamethasone mouthwash in preventing everolimus-related stomatitis in women with breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the use of dexamethasone (Ozurdex) mouthwash for preventing stomatitis in patients with breast cancer(BC).  The use of dexamethasone oral solution was found to significantly reduce the incidence and severity of stomatitis. Some background Everolimus (Afinitor) and exemestane (Aromasin) are mTOR inhibitors...

Read More

How radiotherapy for breast cancer influences long-term the risk of lung cancer and heart disease

How radiotherapy for breast cancer influences long-term the risk of lung cancer and heart disease

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the results of previous trials to determine the effects of breast cancer (BC) radiotherapy (RT) on the long-term risk of developing other health conditions later in life. This study determined that for long-term smokers, the future health risks associated with RT may outweigh the benefits. Some background RT...

Read More

Which prostate cancer patients are at risk of skeletal related events?

Which prostate cancer patients are at risk of skeletal related events?

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell This study investigated whether the likelihood of developing skeletal related events (SREs) could be determined depending on the site of metastasis at diagnosis and other factors in older patients with prostate cancer. The study concluded that the likelihood of developing an SRE was similar among different sites of metastasis, except...

Read More

The beneficial effects of trastuzumab on locoregional control in HER2-positive breast cancer patients.

Posted by on Mar 27, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the effects of trastuzumab (Herceptin) on the locoregional control (management in the area in which it arose) of patients with HER2-positive breast cancer (HER2+BC) following radiotherapy (RT). Trastuzumab administered alongside RT was found to be associated with a significantly reduced rate of locoregional...

Read More

How does hormone receptor status affect patient response to trastuzumab therapy in metastatic breast cancer

How does hormone receptor status affect patient response to trastuzumab therapy in metastatic breast cancer

Posted by on Mar 20, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the clinical factors that influence patient response to trastuzumab (Herceptin) therapy in human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer (MBC). Hormone receptor (HR) status was found to be a possible predictor of a strong response to trastuzumab-based therapy. Some background...

Read More

Neutropenia is associated with improved survival of colorectal cancer patients treated with TAS-102

Neutropenia is associated with improved survival of colorectal cancer patients treated with TAS-102

Posted by on Mar 13, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether neutropenia (NTP; loss of white blood cells) is related to improved survival in colorectal cancer patients treated with TAS-102. Researchers suggested that patients who experience NTP after one month of treatment have an improved overall survival.  Some background Chemotherapy is used to treat...

Read More

Updated guidelines for using radiotherapy after breast removal in breast cancer patients

Updated guidelines for using radiotherapy after breast removal in breast cancer patients

Posted by on Mar 13, 2017 in Breast cancer | 0 comments

In a nutshell This study reviewed updated guidelines for the use of radiotherapy following mastectomy (surgical removal of the breast) in breast cancer. Some background Post-mastectomy radiation therapy (PMRT) is widely accepted for patients with four or more involved axillary (underarm) lymph nodes. The axillary lymph nodes are the first...

Read More

Prostate cancer treatments for elderly men

Prostate cancer treatments for elderly men

Posted by on Mar 6, 2017 in Prostate cancer | 3 comments

In a nutshell The authors aimed to identify the recommended treatments for prostate cancer in men over the age of 70 years. The authors concluded that treatments for local and advanced prostate cancer in elderly men should be individualized, with focus on the health of the patient, to determine the appropriate treatment course. Some background...

Read More

Comparing axillary lymph node ultrasound and fine needle aspiration in breast cancer

Posted by on Mar 4, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether patients with a suspicious axillary lymph node (ALN) but negative fine-needle aspiration result (FNA) can be considered as having node-negative disease (AUN). The study concluded that patients with suspicious ALN on ultrasound but negative FNA results can be treated as having node-negative disease. Some...

Read More